Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Anti-heart failure granules** are an orally administered granule preparation studied at Changzhou De'an Hospital as an adjunct to conventional chronic heart-failure treatment, either alone or together with individualized aerobic exercise. A 90-patient study reported improvements in cardiopulmonary exercise measures, echocardiographic measures, functional capacity, NT-proBNP, and traditional Chinese medicine symptom scores after 12 weeks; the combination with aerobic exercise performed better than either intervention alone. The publicly available sources do not disclose the product's ingredient composition, manufacturer, or molecular mechanism. ([chictr.org.cn](https://www.chictr.org.cn/showproj.html?proj=246853))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on anti-heart failure granules.